Recent Finacing
Recent Raise
Panther Biotechnology acquires undervalued clinical assets and develops enhanced therapeutics for cancer, autoimmune, and viral diseases, advancing targeted TRF-DOX, Numonafide, and TDZD-8 clinical candidates.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor